BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blakeborough A, Ward J, Wilson D, Griffiths M, Kajiya Y, Guthrie JA, Robinson PJ. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology. 1997;203:759-765. [PMID: 9169701 DOI: 10.1148/radiology.203.3.9169701] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Chan VO, Das JP, Gerstenmaier JF, Geoghegan J, Gibney RG, Collins CD, Skehan SJ, Malone DE. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist®)-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Ir J Med Sci 2012;181:499-509. [DOI: 10.1007/s11845-012-0805-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibany N, Schick S, Prokesch RW, Kaider A, Teleky B, Wrba F, Lechner G. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000;11:665-72. [PMID: 10862066 DOI: 10.1002/1522-2586(200006)11:6<665::aid-jmri13>3.0.co;2-d] [Cited by in Crossref: 45] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bruegel M, Gaa J, Waldt S, Woertler K, Holzapfel K, Kiefer B, Rummeny EJ. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol. 2008;191:1421-1429. [PMID: 18941080 DOI: 10.2214/ajr.07.3279] [Cited by in Crossref: 108] [Cited by in F6Publishing: 29] [Article Influence: 7.7] [Reference Citation Analysis]
4 Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-66. [PMID: 10207430 DOI: 10.1148/radiology.210.2.r99fe05459] [Cited by in Crossref: 187] [Cited by in F6Publishing: 158] [Article Influence: 8.1] [Reference Citation Analysis]
5 Goyen M. Right-lobe living related liver transplantation: Evaluation of a comprehensive magnetic resonance imaging protocol for assessing potential donors. Liver Transplantation 2002;8:241-50. [DOI: 10.1053/jlts.2002.30403] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
6 Mantatzis M, Kakolyris S, Amarantidis K, Karayiannakis A, Prassopoulos P. Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate? Eur Radiol 2009;19:1809-16. [PMID: 19238395 DOI: 10.1007/s00330-009-1327-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
7 Kim SH, Choi D, Lim HK, Kim MJ, Jang KM, Kim SH, Lee WJ, Lee J, Jeon YH, Lim JH. Detection of hepatic VX2 carcinomas with ferucarbotran-enhanced magnetic resonance imaging in rabbits: Comparison of nine pulse sequences. European Journal of Radiology 2006;59:413-23. [DOI: 10.1016/j.ejrad.2006.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Lim JS, Kim MJ, Yun MJ, Oh YT, Kim JH, Hwang HS, Park MS, Cha SW, Lee JD, Noh SH. Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol. 2006;7:249-256. [PMID: 17143028 DOI: 10.3348/kjr.2006.7.4.249] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
9 Weichert JP, Lee FT Jr, Chosy SG, Longino MA, Kuhlman JE, Heisey DM, Leverson GE. Combined hepatocyte-selective and blood-pool contrast agents for the CT detection of experimental liver tumors in rabbits. Radiology 2000;216:865-71. [PMID: 10966724 DOI: 10.1148/radiology.216.3.r00se43865] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
10 Albrecht T. Detection and Characterisation of Liver Metastases. In: Lencioni R, editor. Enhancing the Role of Ultrasound with Contrast Agents. Milan: Springer-Verlag; 2006. pp. 53-67. [DOI: 10.1007/88-470-0476-4_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Siegelman ES, Outwater EK. MR imaging techniques of the liver. Radiol Clin North Am. 1998;36:263-286. [PMID: 9520981 DOI: 10.1016/s0033-8389(05)70021-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
12 Yoshiokaa H, Itai Y, Saida Y, Mori K, Mori H, Okumura T. Superparamagnetic iron oxide-enhanced MR imaging for early and late radiation-induced hepatic injuries. Magn Reson Imaging 2000;18:1079-88. [PMID: 11118762 DOI: 10.1016/s0730-725x(00)00192-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Semelka RC, Balci NC, de Beeck BO, Reinhold C. Evaluation of a 10-minute Comprehensive MR Imaging Examination of the Upper Abdomen. Radiology 1999;211:189-95. [DOI: 10.1148/radiology.211.1.r99ap32189] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
14 Yang DM, Jahng GH, Kim HC, Jin W, Ryu CW, Nam DH, Lee YK, Park SY. The detection and discrimination of malignant and benign focal hepatic lesions: T2 weighted vs diffusion-weighted MRI. Br J Radiol. 2011;84:319-326. [PMID: 20959371 DOI: 10.1259/bjr/50130643] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
15 Siegelman ES, Outwater EK. Magnetic resonance imaging of focal and diffuse hepatic disease. Seminars in Ultrasound, CT and MRI 1998;19:2-34. [DOI: 10.1016/s0887-2171(98)90022-1] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
16 Earls JP, Bluemke DA. NEW MR IMAGING CONTRAST AGENTS. Magnetic Resonance Imaging Clinics of North America 1999;7:255-73. [DOI: 10.1016/s1064-9689(21)00021-0] [Cited by in Crossref: 20] [Article Influence: 0.9] [Reference Citation Analysis]
17 Katayama M, Masui T, Kobayashi S, Ito T, Takahashi M, Sakahara H, Nozaki A, Kabasawa H. Fat-suppressed T2-weighted MRI of the liver: Comparison of respiratory-triggered fast spin-echo, breath-hold single-shot fast spin-echo, and breath-hold fast-recovery fast spin-echo sequences. J Magn Reson Imaging 2001;14:439-49. [DOI: 10.1002/jmri.1205] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
18 Zheng WW, Zhou KR, Chen ZW, Shen JZ, Chen CZ, Zhang SJ. Characterization of focal hepatic lesions with SPIO-enhanced MRI. World J Gastroenterol 2002; 8(1): 82-86 [PMID: 11833077 DOI: 10.3748/wjg.v8.i1.82] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
19 Ward J. Use of contrast agents for liver MRI. Radiography 2007;13:e54-72. [DOI: 10.1016/j.radi.2006.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
20 Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology. 2002;222:73-80. [PMID: 11756708 DOI: 10.1148/radiol.2221001599] [Cited by in Crossref: 77] [Cited by in F6Publishing: 64] [Article Influence: 3.9] [Reference Citation Analysis]
21 Konopke R, Bunk A, Kersting S. The Role of Contrast-Enhanced Ultrasound for Focal Liver Lesion Detection: An Overview. Ultrasound in Medicine & Biology 2007;33:1515-26. [DOI: 10.1016/j.ultrasmedbio.2007.04.009] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
22 Kato N, Takahashi M, Tsuji T, Ihara S, Brautigam M, Miyazawa T. Dose-Dependency and Rate of Decay of Efficacy of Resovist on MR Images in a Rat Cirrhotic Liver Model: . Investigative Radiology 1999;34:551. [DOI: 10.1097/00004424-199909000-00001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
23 Said B, Mccart J, Libutti SK, Choyke PL. Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence. Magnetic Resonance Imaging 2000;18:305-9. [DOI: 10.1016/s0730-725x(99)00134-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
24 Ward J, Robinson PJ. COMBINED USE OF MR CONTRAST AGENTS FOR EVALUATING LIVER DISEASE. Magnetic Resonance Imaging Clinics of North America 2001;9:767-83. [DOI: 10.1016/s1064-9689(21)00273-7] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
25 Lim SJ, Lim JS, Choi J, Choi JY, Hyung WJ, Kim HS, Suh J, Kim KW. Nanoscaled iodized oil emulsion as a CT contrast agent for the detection of experimental liver tumors in a rat model. Acad Radiol 2010;17:985-91. [PMID: 20617548 DOI: 10.1016/j.acra.2010.03.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ward J, Robinson PJ, Guthrie JA, Downing S, Wilson D, Lodge JP, Prasad KR, Toogood GJ, Wyatt JI. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology. 2005;237:170-180. [PMID: 16126930 DOI: 10.1148/radiol.2371041444] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 6.9] [Reference Citation Analysis]
27 Rappeport ED, Loft A. Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography. Abdom Imaging. 2007;32:624-634. [PMID: 17710359 DOI: 10.1007/s00261-007-9297-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
28 Cheng WZ, Zeng MS, Yan FH, Rao SX, Shen JZ, Chen CZ, Zhang SJ, Shi WB. Ferucarbotran versus Gd-DTPA-enhanced MR imaging in the detection of focal hepatic lesions. World J Gastroenterol 2007; 13(36): 4891-4896 [PMID: 17828821 DOI: 10.3748/wjg.v13.i36.4891] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
29 Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology. 2001;218:27-38. [PMID: 11152776 DOI: 10.1148/radiology.218.1.r01ja2427] [Cited by in Crossref: 239] [Cited by in F6Publishing: 197] [Article Influence: 11.4] [Reference Citation Analysis]
30 Choi D, Kim SH, Lim JH, Lee WJ, Jang H, Lee SJ, Lim HK. Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced MR Imaging Versus Combined Helical CT During Arterial Portography and CT Hepatic Arteriography. American Journal of Roentgenology 2001;176:475-82. [DOI: 10.2214/ajr.176.2.1760475] [Cited by in Crossref: 61] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
31 Ward J, Chen F, Guthrie JA, Wilson D, Lodge JP, Wyatt JI, Robinson PJ. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology. 2000;214:159-166. [PMID: 10644117 DOI: 10.1148/radiology.214.1.r00ja21159] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 2.6] [Reference Citation Analysis]
32 Ward J, Guthrie JA, Wilson D, Arnold P, Lodge JP, Toogood GJ, Wyatt JI, Robinson PJ. Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology. 2003;228:709-718. [PMID: 12888620 DOI: 10.1148/radiol.2283020376] [Cited by in Crossref: 68] [Cited by in F6Publishing: 57] [Article Influence: 3.6] [Reference Citation Analysis]
33 Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging. 2010;35:511-521. [PMID: 19562412 DOI: 10.1007/s00261-009-9555-2] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
34 Chen R, Lii J, Chou C, Chang T, Chen W, Li C, Tu H. T2-weighted and T1-weighted Dynamic Superparamagnetic Iron Oxide (Ferucarbotran) Enhanced MRI of Hepatocellular Carcinoma and Hyperplastic Nodules. Journal of the Formosan Medical Association 2008;107:798-805. [DOI: 10.1016/s0929-6646(08)60193-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
35 Imam K, Bluemke DA. MR IMAGING IN THE EVALUATION OF HEPATIC METASTASES. Magnetic Resonance Imaging Clinics of North America 2000;8:741-56. [DOI: 10.1016/s1064-9689(21)00641-3] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
36 Morrin MM, Rofsky NM. TECHNIQUES FOR LIVER MR IMAGING. Magnetic Resonance Imaging Clinics of North America 2001;9:675-96. [DOI: 10.1016/s1064-9689(21)00269-5] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
37 Park JM, Kim IY, Kim SW, Lee SM, Kim HG, Kim SY, Shin HC. A comparative study of FDG PET/CT and enhanced multi-detector CT for detecting liver metastasis according to the size and location. Ann Nucl Med 2013;27:217-24. [PMID: 23242953 DOI: 10.1007/s12149-012-0677-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
38 Kim SH, Choi D, Lim JH, Lee WJ, Jang HJ, Lim HK, Lee SJ, Cho JM, Kim SK, Kim GC. Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: a comparative study using seven pulse sequences. Korean J Radiol 2002;3:87-97. [PMID: 12087198 DOI: 10.3348/kjr.2002.3.2.87] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
39 Braga HJ, Imam K, Bluemke DA. MR imaging of intrahepatic cholangiocarcinoma: use of ferumoxides for lesion localization and extension. AJR Am J Roentgenol. 2001;177:111-114. [PMID: 11418408 DOI: 10.2214/ajr.177.1.1770111] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
40 Rinaldi P, Costantini M, Belli P, Giuliani M, Bufi E, Fubelli R, Distefano D, Romani M, Bonomo L. Extra-mammary findings in breast MRI. Eur Radiol 2011;21:2268-76. [PMID: 21688004 DOI: 10.1007/s00330-011-2183-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
41 Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G. Let's go out of the breast: prevalence of extra-mammary findings and their characterization on breast MRI. Eur J Radiol 2014;83:930-4. [PMID: 24656879 DOI: 10.1016/j.ejrad.2014.02.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
42 Namkung S, Zech CJ, Helmberger T, Reiser MF, Schoenberg SO. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. J Magn Reson Imaging 2007;25:755-65. [PMID: 17335040 DOI: 10.1002/jmri.20873] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
43 Kumano S, Murakami T, Kim T, Hori M, Okada A, Sugiura T, Noguchi Y, Kawata S, Tomoda K, Nakamura H. Using superparamagnetic iron oxide-enhanced MRI to differentiate metastatic hepatic tumors and nonsolid benign lesions. AJR Am J Roentgenol 2003;181:1335-9. [PMID: 14573430 DOI: 10.2214/ajr.181.5.1811335] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
44 Keogan MT, Edelman RR. Technologic advances in abdominal MR imaging. Radiology. 2001;220:310-320. [PMID: 11477231 DOI: 10.1148/radiology.220.2.r01au22310] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 4.1] [Reference Citation Analysis]
45 Chen F, Ward J, Robinson P. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents. Magnetic Resonance Imaging 1999;17:549-56. [DOI: 10.1016/s0730-725x(98)00193-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
46 Reimer P, Jähnke N, Fiebich M, Schima W, Deckers F, Marx C, Holzknecht N, Saini S. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology. 2000;217:152-158. [PMID: 11012438 DOI: 10.1148/radiology.217.1.r00oc31152] [Cited by in Crossref: 141] [Cited by in F6Publishing: 122] [Article Influence: 6.4] [Reference Citation Analysis]
47 Scott J, Ward J, Guthrie J, Wilson D, Robinson P. MRI of liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. Magnetic Resonance Imaging 2000;18:297-303. [DOI: 10.1016/s0730-725x(00)00116-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
48 Ward J. New MR techniques for the detection of liver metastases. Cancer Imaging 2006;6:33-42. [PMID: 16766267 DOI: 10.1102/1470-7330.2006.0007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
49 Scharitzer M, Ba-Ssalamah A, Ringl H, Kölblinger C, Grünberger T, Weber M, Schima W. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol. 2013;23:2187-2196. [PMID: 23519439 DOI: 10.1007/s00330-013-2824-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
50 Limanond P, Raman SS, Sayre J, Lu DS. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners. J Magn Reson Imaging 2004;20:640-7. [DOI: 10.1002/jmri.20165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology. 2003;228:719-726. [PMID: 12881583 DOI: 10.1148/radiol.2283020735] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.1] [Reference Citation Analysis]